SDGR Schrödinger, Inc.
Schrödinger, Inc. (SDGR) is expected to report earnings on February 3, 2027, after the market close. The consensus earnings estimate is a loss of $0.05 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of -1.1% since its last earnings release on November 4, 2026.
Sign in or subscribe to unlock sentiment, short interest, and technical indicators.
Whisperings™
About Schrödinger, Inc.
Schrödinger is transforming the way therapeutics and materials are discovered. Schrödinger has pioneered a physics-based software platform that enables discovery of high-quality, novel molecules for drug development and materials applications more rapidly and at lower cost compared to traditional methods.
Sector
Healthcare
Industry
Research Services
Held By 2 ETFs, by dollar flow
Charts powered in part by Lightweight Charts™ by TradingView.